The JSS Academy of Higher Education and Research (JSSAHER) in Mysuru will soon begin human trials for Sputnik V, a COVID-19 vaccine developed by Russia.
The Hyderabad-based Dr. Reddy’s Laboratories, which had received approval for clinical trials of Sputnik V in India, had chosen JSSAHER as one of the sites for the trials.
“The site inspection has been completed and approved. We will begin trials soon after receiving clearance in the regard,” said JSSAHER Pro-Chancellor Suresh told The Hindu.
JSSAHER, which is already carrying out phase 2 and 3 trials for vaccine candidate Covishield, developed by Oxford University and pharmaceutical company AstraZeneca, will also begin in a week clinical trials of Novavax, another vaccine candidate developed by a U.S. biotechnology company.
“We will be commencing phase 2 and 3 trials for Novavax in a week. If the ongoing trials for BCG booster dose in elderly people is taken into account, JSSAHER will be carrying out four human trials simultaneously,” Dr. Suresh said.
